Glaukos Corporation to Release Third Quarter 2018 Financial Results after Market Close on November 7

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, plans to release third quarter 2018 financial results after the market close on Wednesday, November 7, 2018. The company’s management will discuss the results during a conference call and simultaneous we

Full Story →